Commodore Capital LP - 10 Dec 2024 SCHEDULE 13G Report for Cardiff Oncology, Inc. Common Stock, $0.0001 par value (CRDF)

Filing Manager
Commodore Capital LP
Reporting Manager
COMMODORE CAPITAL LP
Security
Cardiff Oncology, Inc. Common Stock, $0.0001 par value
Symbol
CRDF
Shares outstanding
66.5M shares
Disclosed Ownership
5.38M shares
Ownership
8.1%
Form type
SCHEDULE 13G
Filing time
17 Dec 2024, 16:06:19 UTC
Date of event
10 Dec 2024
Next filing
14 Aug 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
COMMODORE CAPITAL LP 8.1% 5.38M 0 5.38M /s/ Michael Kramarz Michael Kramarz, Managing Partner
Commodore Capital Master LP 8.1% 5.38M 0 5.38M /s/ Michael Kramarz Michael Kramarz, Authorized Signatory